Extracellular gadolinium-based contrast media: an overview.
about
Toxicity of MRI and CT contrast agentsNon-invasive diagnostic imaging of colorectal liver metastasesUse of contrast agents in oncological imaging: magnetic resonance imaging.Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status.Responsive MRI agents for sensing metabolism in vivo.Facile synthesis of non-ionic dimeric molecular resonance imaging contrast agent: its relaxation and luminescence studies.MR imaging of articular cartilage physiology.Gold-silver alloy nanoshells: a new candidate for nanotherapeutics and diagnostics.Curium(III) citrate speciation in biological systems: a europium(III) assisted spectroscopic and quantum chemical study.Multiparametric MRI biomarkers for measuring vascular disrupting effect on cancerEndogenous assessment of chronic myocardial infarction with T(1ρ)-mapping in patientsBlood Pool Contrast-enhanced Magnetic Resonance Angiography with Correlation to Digital Subtraction Angiography: A Pictorial Review.Transplant renal artery stenosis: clinical manifestations, diagnosis and therapy.On the use of molecular weight cutoff cassettes to measure dynamic relaxivity of novel gadolinium contrast agents: example using hyaluronic Acid polymer complexes in phosphate-buffered salineMagnetic resonance imaging of the pancreas in streptozotocin-induced diabetic rats: Gadofluorine P and Gd-DOTA.Lumazine Synthase Protein Nanoparticle-Gd(III)-DOTA Conjugate as a T1 contrast agent for high-field MRIMRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancementOptimization of saturation-recovery dynamic contrast-enhanced MRI acquisition protocol: monte carlo simulation approach demonstrated with gadolinium MR renography.Is administration of gadolinium-based contrast media to pregnant women and small children justified?Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging.Contrast-enhanced peripheral MRA: technique and contrast agents.Interference of medical contrast media on laboratory testing.Gadolinium contrast agents for CNS imaging: current concepts and clinical evidence.Endogenous contrast MRI of cardiac fibrosis: beyond late gadolinium enhancement.A systematic comparison of cardiovascular magnetic resonance and high resolution histological fibrosis quantification in a chronic porcine infarct model.Magnetic Resonance Imaging of the Liver (Including Biliary Contrast Agents) Part 1: Technical Considerations and Contrast Materials.Status and trends in the development of clinical diagnostic agents.Advanced MRI of articular cartilage.Diffusion-weighted imaging for assessment of synovial inflammation in juvenile idiopathic arthritis: a promising imaging biomarker as an alternative to gadolinium-based contrast agents.Cellular internalization and morphological analysis after intravenous injection of a highly hydrophilic octahedral rhenium cluster complex - a new promising X-ray contrast agent.A Japanese, Multicenter, Open-label, Phase 3 Study to Investigate the Safety and Efficacy of Gadobutrol for Contrast-enhanced MR Imaging of the Central Nervous System.Late adverse events after enhanced and unenhanced MRI and CT: a prospective study.Intra-individual, randomised comparison of the MRI contrast agents gadobutrol versus gadoteridol in patients with primary and secondary brain tumours, evaluated in a blinded read.Intra-individual randomised comparison of gadobutrol 1.0 M versus gadobenate dimeglumine 0.5 M in patients scheduled for preoperative breast MRI.Comparison of dynamic contrast-enhanced MRI and dynamic contrast-enhanced CT biomarkers in bladder cancer.Functional lung MRI for regional monitoring of patients with cystic fibrosis.Intrathecal Injection of Gadobutrol: A Tale of Caution.Candidate biomarkers of extravascular extracellular space: a direct comparison of apparent diffusion coefficient and dynamic contrast-enhanced MR imaging--derived measurement of the volume of the extravascular extracellular space in glioblastoma mulA direct comparison of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer detection and prediction of aggressiveness.Bioaccumulation of gadolinium in freshwater bivalves.
P2860
Q22306013-1AAD928D-1F58-4F66-B835-35D8FA58B3CFQ26798428-107DC3AB-9A5A-42CB-9B27-F4F8B86C8A30Q30669419-E2AB4C5E-CBCE-4486-8780-AB1746ED5A3DQ31045014-A8D98379-CCC7-4742-AEA3-C855D4FCA40AQ33415333-D2ACD134-4075-4142-B04E-80574D571E97Q33828889-B0885892-C58F-4822-B2ED-BF7C1443D24DQ33930002-3347F416-5D23-4B0D-9488-C43C3C3DC980Q34047561-E10DD3AF-A835-4443-8D46-BD27F07117EBQ34426120-10FC32F8-4537-4984-941C-3F38D9BEE960Q34538659-CD61626D-FF6E-4952-BD73-B6B295450D4DQ34746688-D3F1D003-F6A8-4DDB-A296-001F79CF3C98Q34779865-49301850-8400-4CB3-A529-98054E1F1117Q35026504-E53B9545-D6D5-4199-B99F-D49F07EF2101Q35608648-528E4956-8417-4817-96B0-46F8EBCFD956Q35625364-528380EE-7DF0-4D2D-907F-9F7862F88DA5Q36192560-206EA9C4-C2DA-4A32-B7ED-2CAE9A41E4EBQ37152523-66813E43-AAB9-42EB-BAF6-D7051F3B9042Q37551153-03A1516E-39E8-4A1F-AAA7-08E1CCE04CC5Q37934729-0DB3D05F-78F8-4055-AC14-44847F7DBE6CQ38007857-A248A799-1450-425B-A1BF-27D44E33B815Q38030503-7D48D12C-CF8A-4A30-8285-1CC93D34B5D1Q38195845-E688A59B-2C50-418B-81DB-DC8C1791E552Q38213840-6729771B-6A66-4298-8C52-FFCB8CDA0777Q38236811-64909C09-AE1E-4044-96D9-48CB2F5E61F4Q38724882-42DE8F74-7E36-42BD-AC42-2C56D950EE33Q38981471-5CD84458-09D3-4E6E-A8AF-F2784F147FF5Q38995734-02B85DBC-F0FD-4147-A8C5-789A238E6C13Q39608425-0C274D9A-B7CD-4F08-A5CB-19FBAE44D466Q40174823-829622F7-0991-4E3C-A90A-C43E5237F106Q40636025-24DAB96E-B876-4DC5-BED5-2B15ABF9D8E5Q42359382-10D0D32C-68DE-4880-ACED-492A5249F227Q43600641-8940AF00-1621-41E2-9CB0-8CA98FDA4A9CQ43683957-630DC1E1-582D-448C-B0B5-CE831C363B8EQ45816828-2F96D541-1ECC-4795-A9B2-9B955085FF8EQ46140795-4F0FB0DD-23DE-43A4-92F8-2F8D1A445234Q47142409-37810DA5-FC7D-4890-908B-DE4B578D116FQ47768309-CA20FBB7-664F-45C8-823F-6FAB2465B1D4Q48426682-891EC1A3-1361-40BC-842D-720C04595B1BQ49853629-21CE639D-01B6-49B8-8400-578AAADDF15BQ50762153-85D53C3F-7714-4A5A-8328-8678540B79D6
P2860
Extracellular gadolinium-based contrast media: an overview.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Extracellular gadolinium-based contrast media: an overview.
@en
Extracellular gadolinium-based contrast media: an overview.
@nl
type
label
Extracellular gadolinium-based contrast media: an overview.
@en
Extracellular gadolinium-based contrast media: an overview.
@nl
prefLabel
Extracellular gadolinium-based contrast media: an overview.
@en
Extracellular gadolinium-based contrast media: an overview.
@nl
P1476
Extracellular gadolinium-based contrast media: an overview.
@en
P2093
Aart J Van Der Molen
Marie-France Bellin
P304
P356
10.1016/J.EJRAD.2008.01.023
P577
2008-03-20T00:00:00Z